Eyenovia induces warrant exercise raising $1.0M; issues new warrants with 200% coverage at $0.0659

HYPERION DEFI, INC.

Investor exercised 15,769,445 existing warrants at reduced price of $0.0659, gross proceeds ~$1.0M.
Issued Series A and B warrants to purchase up to 31.5M shares (200% coverage) at $0.0659 per share.
New warrants require stockholder approval before exercisable; meeting to be held within 120 days.
Company must file resale registration statement for new warrant shares by Feb 28, 2025; effective within 120 days of issuance.
Chardan Capital received 4.5% cash fee on gross proceeds for financial advisory.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.